OTC: EKTAF - Elekta AB (publ)

Rentabilidad a seis meses: -10.24%
Rendimiento de dividendos: +2.05%
Sector: Healthcare

Calendario de promoción Elekta AB (publ)


Acerca de la empresa Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

más detalles
It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета sek
Див.доход ао 4.07
Дивиденд ао 0.2275
Сайт https://elekta.com
Цена ао 5.61
Cambio de precio por día: 0% (5.61)
Cambio de precio por semana.: -0.8834% (5.66)
Cambio de precio por mes: +3.12% (5.44)
Cambio de precio en 3 meses.: -4.92% (5.9)
Cambio de precio en seis meses: -10.24% (6.25)
Cambio de precio por año: -25.79% (7.56)
Cambio de precio en 3 años.: -58.41% (13.49)
Cambio de precio en 5 años.: -34.46% (8.56)
Cambio de precio en 10 años.: 0% (5.61)
Cambio de precio desde principios de año.: -0.708% (5.65)

Subestimación

Nombre Significado Calificación
P/S 1.74 8
P/BV 2.93 6
P/E 24.24 6
EV/EBITDA 10.97 7
Total: 6.13

Eficiencia

Nombre Significado Calificación
ROA, % 4.23 1
ROE, % 12.7 4
Total: 3.83

Dividendos

Nombre Significado Calificación
Div yield, % 2.05 5.13
DSI 0.8571 8.57
Total: 4.64

Deber

Nombre Significado Calificación
Debt/EBITDA 2.21 6
Total: 4.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 24.09 4
Rentabilidad Ebitda, % 2.18 1
Rentabilidad EPS, % 19.99 3
Total: 4.4



Supervisor Título profesional Pago año de nacimiento
Dr. Laurent Leksell Founder & Chairman 1.64M 1952 (73 año)
Mr. Gustaf Salford President & CEO 14.62M 1977 (48 años)
Mr. Tobias Hagglov Chief Financial Officer N/A 1978 (47 años)
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel N/A 1966 (59 años)
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs N/A
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer N/A 1985 (40 años)
Mr. John Lapré President of Brachy & Neuro Solutions N/A 1964 (61 año)
Mr. Maurits Wolleswinkel President of Linac & Software Solutions N/A 1971 (54 año)
Mr. Habib Nehme Chief Commercial Officer N/A 1964 (61 año)
Mr. Peter Nyquist Head of Investor Relations N/A 1965 (60 años)

DIRECCIÓN: Sweden, Stockholm, Hagaplan 4 - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://elekta.com